gabapentin

Generic: gabapentin

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler asclemed usa, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

gabapentin 600 mg/1

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-836
Product ID 76420-836_359e91ba-a244-6357-e063-6394a90a9542
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214957
Listing Expiration 2026-12-31
Marketing Start 2021-10-01

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420836
Hyphenated Format 76420-836

Supplemental Identifiers

RxCUI
310433 310434
UNII
6CW7F3G59X
NUI
N0000008486

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA214957 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 600 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (76420-836-01)
  • 500 TABLET in 1 BOTTLE (76420-836-05)
  • 120 TABLET in 1 BOTTLE (76420-836-12)
  • 30 TABLET in 1 BOTTLE (76420-836-30)
  • 60 TABLET in 1 BOTTLE (76420-836-60)
  • 90 TABLET in 1 BOTTLE (76420-836-90)
source: ndc

Packages (6)

76420-836-01 100 TABLET in 1 BOTTLE (76420-836-01) 76420-836-05 500 TABLET in 1 BOTTLE (76420-836-05) 76420-836-12 120 TABLET in 1 BOTTLE (76420-836-12) 76420-836-30 30 TABLET in 1 BOTTLE (76420-836-30) 76420-836-60 60 TABLET in 1 BOTTLE (76420-836-60) 76420-836-90 90 TABLET in 1 BOTTLE (76420-836-90)

Ingredients (1)

gabapentin (600 mg/1)

Linked Drug Pages (1)

GABAPENTIN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "359e91ba-a244-6357-e063-6394a90a9542", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310433", "310434"], "spl_set_id": ["1f1203f4-2184-4e13-e063-6394a90a4330"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (76420-836-01)", "package_ndc": "76420-836-01", "marketing_start_date": "20240807"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (76420-836-05)", "package_ndc": "76420-836-05", "marketing_start_date": "20240807"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (76420-836-12)", "package_ndc": "76420-836-12", "marketing_start_date": "20250521"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-836-30)", "package_ndc": "76420-836-30", "marketing_start_date": "20240807"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-836-60)", "package_ndc": "76420-836-60", "marketing_start_date": "20240807"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-836-90)", "package_ndc": "76420-836-90", "marketing_start_date": "20240807"}], "brand_name": "GABAPENTIN", "product_id": "76420-836_359e91ba-a244-6357-e063-6394a90a9542", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "76420-836", "generic_name": "Gabapentin", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "600 mg/1"}], "application_number": "ANDA214957", "marketing_category": "ANDA", "marketing_start_date": "20211001", "listing_expiration_date": "20261231"}